Yuksel, IlkanKaplan, Mustafa2024-06-122024-06-1220112147-2270https://hdl.handle.net/20.500.14551/23383The result of epidemiyologic researchs shows us prostat cancer is the second common cancer after lung cancer. Because of high incidence of prostat cancer, morbitities of treatment options and high costs, prevention of prostat cancer become popular. After explaning the mechanisms of prostat carcinogenez, the idea of some agents can be usefull to prevent prostat cancer is suggested. Succesfull results get from the resarch with 5 alfa reductase and estrogen receptor antagonists, but the resarchs with nonsteroidal antiinflamtory drugs, selenium, vitamin D, lycopene can't give us absolute results, so we need more researchs with these agents.trinfo:eu-repo/semantics/closedAccessProstate CancerPrevention5 Alfa Reduktase InhibitorEstrogen Receptor AntagonistsSeleniumVitamin ELycopeneVitamin DNonsteroidal Antiinflamtory DrugsGreen TeaReview Article1021721N/AWOS:000219390000004